Kennedy/Grassley Imports Criminal Liability To Global Drug Safety Efforts
Executive Summary
A senior drug company officer or director would be required personally to certify the veracity of product applications and safety submissions to FDA, under Sens. Edward Kennedy, D-Mass., and Chuck Grassley's, R-Iowa, bill to improve safety in global drug manufacturing and distribution
You may also be interested in...
Rx Manufacturing Safety Bill Resurfaces Without Inspection Fees
FDA's foreign and domestic oversight powers would increase under the legislation, which has been stripped down in an apparent effort to speed passage.
High-Risk Drug Imports To Be Delayed, FDA PREDICTs; Focus On Data Quality Can Avoid New 20 Percent Dragnet
An FDA information technology system designed to identify high-risk imports for possible inspection should speed U.S. entry for about 80 percent of FDA-regulated products coming into the country
High-Risk Drug Imports To Be Delayed, FDA PREDICTs; Focus On Data Quality Can Avoid New 20 Percent Dragnet
An FDA information technology system designed to identify high-risk imports for possible inspection should speed U.S. entry for about 80 percent of FDA-regulated products coming into the country